• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

cook ir

  1. Is transformation the beginning of the end for Cook Vascular or the start of something great?

    Cook vascular seems like it is on a knife's edge. Transforming a company and bringing together separate divisions that have for years operated independently will be very challenging. How does everyone feel? Can we make this happen and turn Cook Vascular into something great, or will this be a...